Skip to main content

Table 2 Unusual tumours in patients with Lynch syndrome

From: Thyroid cancer in a patient with a germline MSH2 mutation. Case report and review of the Lynch syndrome expanding tumour spectrum

Tumour type

Age

Gene

Mutation

MSI

IHC MLH1

IHC MSH2

IHC MSH6

Ref.

Non-Hodgkin's lymphoma

48

MSH2

large rearrangement

high

+

-

-

45

Rhabdomyosarcoma, pleomorphic

34

MSH2

not published

high

+

-

ND

46

Breast carcinoma, ductal

49

MSH2

c.1705-1706 del GA

high

+

-

-

3

Fibrous histiocytoma, malignant

45

MSH2

p.G429X

high

+

-

ND

4

Adrenal cortical carcinoma

34

MSH2

c.IVS10+1G>A

low

+

-

ND

18

Thyroid carcinoma, anaplastic

39

MSH2

p.Q824X

low

+

-

ND

18

Thyroid carcinoma, undifferentiated

44

MSH2

c.1704_1705 del AG

low

+

-

-

C

Pancreatic medullary carcinoma

63

MSH2

c.C1147T p.R383X

high

+

-

-

47

Prostate adenocarcinoma

61

MSH2

c.del exon 5

high

+

-

-

48

Liposarcoma

40

MSH2

c.del AT codon 677

ND

+

-

ND

49

Hepatic cholangiocarcinoma, mucinous

41

MSH2

c.T2026C

high

+

-

-

50

Uterine carcinosarcoma

46

MLH1

c.G1896C p.E632D

ND

-

+

ND

51

Renal cell carcinoma, clear cellA

51

MLH1

c.C1528T

high

-

ND

ND

1

Breast carcinomaA, ductal

34

MLH1

c.C1528T

high

-

ND

ND

1

Breast carcinoma, male ductal

71

MLH1

4 bp dup in codon 755-756

high

NDB

ND

ND

52

Breast carcinoma, male

46

MLH1

c.2215-2218 dup AAAC

high

NDB

ND

ND

2

  1. ND - not determined, IHC - results from immunohistochemical staining of the tumour for the protein coded by that gene, MSI - classification of the tumour microsatellite instability test results
  2. Ain this South-African family 5 breast cancer patients and a relative with renal cell cancer all carried the same mutation and showed microsatellite instability and loss of MLH1 protein in their tumours
  3. Bin this tumour loss of heterozygosity for MLH1 was detected
  4. Cpatient reported in this paper